Cell Research

 
Stock Quotes for Cell Research top ^
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Type: Slow Growth
Sign-up for pfnd investment picks
  • Industry: Medical Devices
  • Sector: Healthcare
Sign-up for ckntf investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
Sign-up for 031390 investment picks
  • Industry: Medical Care
  • Sector: Healthcare
Sign-up for scal investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
Sign-up for lvcly investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Distressed
Sign-up for bcli investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Distressed
Sign-up for actc investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
Sign-up for lct investment picks
  • Industry: Electronic Components
  • Sector: Technology
  • Stock Style: Small Core
Sign-up for cfu investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Distressed
Sign-up for bcli investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Distressed
Sign-up for actc investment picks
  • Industry: Diversified Industrials
  • Sector: Industrials
  • Stock Type: Distressed
Sign-up for mcelq investment picks
  • Industry: Medical Care
  • Sector: Healthcare
  • Stock Type: Slow Growth
Sign-up for ccel investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Type: Speculative Growth
Sign-up for isco investment picks
  • Industry: Electronic Components
  • Sector: Technology
  • Stock Style: Small Value
Sign-up for 2483 investment picks
  • Industry: Luxury Goods
  • Sector: Consumer Cyclical
  • Stock Type: Distressed
Sign-up for tcel investment picks
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
Sign-up for efli investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
Sign-up for 049960 investment picks

 
News Articles for Cell Research top ^
The Mantle-Cell and Follicular Lymphoma Tests Were Validated In Research Collaborations With Memorial Sloan Kettering and Have Been Successfully Licensed Under Both CLIA and New York State Regulations Tests Address Over One-Third of non-Hodgkin Lymphomas And Will Be Made Available As Part of Comprehensive Testing Programs To Provide Targeted Diagnostic And Prognostic Information RUTHERFORD, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, today announced it has received CLIA and New York state approvals for clinical use of its proprietary mature B-cell neoplasm array, or MatBA ® for Follicular Lymphoma (MatBA ® -FL) and Mantle-Cell Lymphoma (MatBA ® -MCL). Both tests further extend the portfolio in hematologic cancers being developed by CGI and both were developed and validated via a research collaboration with Memorial Sloan-Kettering Cancer Center.
Sign-up for Cancer Genetics Launches Genomic Tests for Follicular Lymphoma and Mantle Cell Lymphoma - Further Extends Unique Position in Targeted Testing of Hematologic Cancers investment picks
2014/5/16
/PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) CEO and President, Richard Garr , will present at the World Stem Cells & Regenerative Medicine Congress, on Thursday, May 22 , at 11:35 a.m. BST in London, UK ( http://www.terrapinn.com/conference/stem-cells/index.stm ). Neuralstem is currently in a Phase II clinical trial to treat ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) with its NSI-566 stem cells and has been approved to commence a Phase I study in spinal cord injury with the same cells.
Sign-up for Neuralstem CEO, Richard Garr, to Present at World Stem Cells & Regenerative Medicine Congress and Give Update on Trials investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Cell Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Caza Oil  |  Next: Cell Technology